About Mechanisms in Myelodysplastic Syndromes

Mechanisms in Myelodysplastic Syndromes is an online CME resource, with content developed by an expert, Dr. David P. Steensma.

The content on this Website is intended for medical oncologists, hematologists, stem cell transplant physicians, and other interested healthcare professionals who manage and treat patients with Myelodysplastic Syndromes (MDS).

The purpose of this Website is to provide an e-learning resource about the mechanisms in MDS. Each comprehensive learning module includes:
  • Text, authored by a leading expert in the treatment and management of Myelodysplastic Syndromes
  • Slide presentation
  • Clinical case study
  • Medical animation
  • Physician self-evaluation questionnaires
Start Module
Content Highlights
In 2010, at least 15,000 new cases of MDS will be diagnosed in the United States, with an overall incidence rate of >4.3 cases per 100,000. However, MDS is not well captured by tumor registries, which until 2001 were not required to report MDS as a cancer to the National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) program. A recent study of 2003 Medicare data estimated that the number of MDS cases diagnosed per year is actually more than 45,000.

Please register to learn more

Program Faculty

Dr David Steensma

About Us Contact Us Terms of Use Privacy Policy Technical Requirements Help